Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.

Arizona is bringing back its iconic 'cactus' logo to the McKale Center floor, and asking fans exactly how to do so. The school produced four images of what the court could look like, all of which ...

According to DelveInsight’s analysis, the current developmental pipeline for osteoarthritis is robust, with several companies initiating clinical trials to investigate new treatment options or improve ...

Viking Therapeutics Inc. + Watchlist Alert VKTX US Open Last Updated: Jun 20, 2025 12:51 p.m. EDT Real time quote $ 25.97-0.31-1.18% Previous Close $26.28 Toggle Chart Options Advanced Charting ...